20 mg & 40 mg
: Treatment of erosive reflux esophagitis in adults & adolescents ≥12 yr, & Zollinger Ellison syndrome in adults. 20 mg:
Long-term management of patients w/ healed esophagitis to prevent relapse, symptomatic treatment of GERD in adults & adolescents ≥12 yr. Adults: In combination w/ appropriate antibacterial therapeutic regimens for the eradication of H. pylori
& healing of H. pylori
associated duodenal ulcer, & prevention of relapse of peptic ulcers in patients w/ H. pylori
associated ulcers. Healing of gastric ulcers associated w/ NSAID therapy. Prevention of gastric & duodenal ulcers associated w/ NSAID therapy, in patients at risk. 40 mg:
Adults: Prolonged treatment after IV induced prevention of rebleeding of peptic ulcers.